Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC labeling for the elderly

This article was originally published in The Tan Sheet

Executive Summary

New York State Assembly bill 9314 would require all OTCs taken orally bear the cautionary statement, "Warning to persons sixty years of age and older: It is recommended that you consult a physician or pharmacist with regard to appropriate drug usage." Introduced Jan. 13 and referred to the Committee on Consumer Affairs & Protection, the bill is identical to Senate bill 3744, introduced last March. In a memorandum of support, Sen. Serphin Maltese (R) notes the elderly often take multiple drugs simultaneously, increasing "their chance of experiencing an adverse reaction...[and] the potential for drug interactions." He also notes OTCs can reduce Rx drugs' effectiveness. "Pharmacists and physicians are in a key position to alert senior citizens to proper usage and prolonged effects of multiple drug interactions," the memo concludes
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS090817

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel